An experimental molecule 'reprograms' the brain's defenses against Alzheimer's disease
Reported byMedicalXpress ↗·Sourced by Goodlede
OLE, an experimental molecule, restores protective function in brain immune cells (microglia) to enclose and reduce beta-amyloid plaques linked to Alzheimer's disease, published in Cell Death and Disease.
Early-stage experimental compound; human trials not yet confirmed in excerpt
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at MedicalXpress
Read original story ↗↻ Refreshed daily
More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Social Justice
Ireland is now paying artists a basic income. Will it catch on?
Positive News · Verified
Science
These 'master' proteins protect us from deadly mutations — and could inspire new drugs
Nature News · Caution
Environment
'I don't like being stuck in an office': the young people helping plant a ring of trees around London
Guardian Environment · Verified